Ty Pendlebury has worked at CNET since 2006. He lives in New York City where he writes about streaming and home audio. Expertise Ty has worked for radio, print, and online publications, and has ...

For some years industry observers have been asking what Merck & Co can do to reduce its reliance on blockbuster cancer immunotherapy Keytruda. Now, it seems a key part of that effort will come ...

Bristol-Myers Squibb’s multiple sclerosis therapy ozanimod has been approved by the FDA right on schedule, but the company has put the launch on ice while it waits for the coronavirus pandemic ...

said. "The CMA has taken a gamble with the package of remedies it has settled on." Here in Money, our most popular posts of the week, judging by traffic, reflected a big Rightmove survey looking ...

Delhi Elections 2025: One-Phase Polling Likely, Voting on 6th February, Counting on 8th February Delhi Elections: Ramvir Singh Bidhuri Makes Bold Claim Ahead of Election Announcement ...